What question did this study set out to answer?

To examine the incidence, specific patterns, and metabolic predictors of dyslipidemia in women diagnosed with polycystic ovary syndrome.

September 1, 2010Gynecological Endocrinology

Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors

View Full Paper

Ask AI

Bookmark

Why the study?

Does polycystic ovary syndrome increase the incidence of dyslipidemia in women?

Key Points

To examine the incidence, specific patterns, and metabolic predictors of dyslipidemia in women diagnosed with polycystic ovary syndrome.
Evaluated 142 women with PCOS (mean age 25.12 years, mean BMI 29.1 kg/m²; 30.2% normal weight, 38.0% overweight, 31.6% obese) alongside 31 age- and BMI-matched eumenorrheic controls lacking hyperandrogenism.
Measured lipid parameters (HDL-C, LDL-C, total cholesterol, and triglycerides) and analyzed independent predictors including glucose, fasting insulin, and HOMA-IR.
Dyslipidemia incidence was more than twice as high in the PCOS cohort compared to controls (76.1% vs. 32.25%), characterized primarily by low HDL-C (57.6%) and elevated triglycerides (28.3%).
HDL-C was significantly reduced across all PCOS subgroups compared to normal controls, with glucose (p = 0.004) and fasting insulin (p = 0.01) acting as independent predictors.
Triglyceride levels were independently predicted by age (p = 0.003) and HOMA-IR (p = 0.03), whereas age independently predicted total cholesterol (p = 0.02) and LDL-C (p = 0.033).

Structured PICO

Does polycystic ovary syndrome increase the incidence of dyslipidemia in women?

Population

142 women with polycystic ovary syndrome (PCOS), average age 25.12 years, average BMI 29.1 kg/m2, and 31 eumenorrheic women matched for BMI and age as controls.

Comparator

Eumenorrheic women matched for BMI and age, with no evidence of hyperandrogenism

Outcome

Incidence and pattern of dyslipidemiasurrogate

Dyslipidemia is highly prevalent in women with PCOS, primarily driven by low HDL-C levels, highlighting the need for cardiovascular risk screening in this population.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May warrant lipid screening in PCOS; leaves open independent association after confounder adjustment.

Cite This Study

Rocha et al. (2010) studied this question.

synapsesocial.com/papers/6a84b3b57e01a96bc18e3d25 https://doi.org/10.3109/09513590.2010.508852

Topics

Lipid management

View Full Paper

Ask AI

Bookmark

Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider